))
Note to File is a podcast for clinical research sites - interviews, best practices, and candid commentary from Brad Hightower, founder of Hightower Clinical and clinical research professional.
…
continue reading
Welcome to the Wealth Management Invest Podcast. David Bodamer delves into the strategic insights of financial advisors and Chief Investment Officers (CIOs) from leading RIAs, including the increasing adoption of alternative investments to enhance the conventional 60/40 portfolio. Episodes showcase engaging discussions with top asset managers, shedding light on the ever-evolving landscape of private investment offerings, cutting-edge technology, and the latest developments in traditional ETF ...
…
continue reading
1
Note to File Hits the Road and Reverse Mergers
27:04
27:04
Play later
Play later
Lists
Like
Liked
27:04
In this episode, we discuss upcoming conferences like Innovation Gathering, Veeva Summit, and SOS, and explore how these events are elevating site voices and fostering real connections in the industry. We also touch on the recent Circuit Clinical/Lightship merger news and talk about the importance of networking and support during industry layoffs. …
…
continue reading
1
AI, Ethics & Cookies: Clinical Research Trends with Dan Schell
55:10
55:10
Play later
Play later
Lists
Like
Liked
55:10
Join Brad, Denali, and guest Dan Schell from Clinical Leader for a lively and insightful conversation on the latest trends in clinical research. From the real-world impact of AI and the evolution of site networks to the challenges of technology adoption and industry ethics, this episode dives deep into what’s shaping the future of clinical trials. …
…
continue reading
1
Catfish, Cancer Conferences, and Clinical Research Chaos
33:28
33:28
Play later
Play later
Lists
Like
Liked
33:28
Join us for a lively episode where we kick things off with tales of catfish, noodling, and regional fishing quirks before diving into the world of clinical research. We discuss the latest cancer center conferences, the persistent challenges facing the industry, and why so many professionals are still relying on spreadsheets and workarounds. Plus, w…
…
continue reading
1
Sites as Customers: Transforming Clinical Research Relationships with Laura O'Donnell
54:34
54:34
Play later
Play later
Lists
Like
Liked
54:34
Laura O'Donnell from GSK challenges the traditional sponsor-site relationship in clinical research. She advocates for treating sites as true customers, not just vendors, by emphasizing transparency, human connection, and meaningful engagement. We dive deep into the challenges sites face, from tech complexity to communication gaps, and explore how t…
…
continue reading
1
The State of Clinical Research: A Candid Conversation with Dr. Robert Califf
29:52
29:52
Play later
Play later
Lists
Like
Liked
29:52
Former FDA Commissioner Dr. Robert Califf provides a brutally honest assessment of the current clinical research landscape. He discusses the critical challenges facing medical innovation, from overly complex clinical trials to profit-driven healthcare systems. Dr. Califf offers insights into why clinical research has become increasingly difficult, …
…
continue reading
1
HIPAA Myths, Industry Risks and White Hot Rage
55:23
55:23
Play later
Play later
Lists
Like
Liked
55:23
In this electrifying episode, legal experts Darshan Kulkarni and Edye Edens dive deep into the complex world of clinical research. From HIPAA compliance and corporate practice of medicine to the hidden risks facing research sites, they break down critical legal insights with their signature wit and candor. Prepare for an eye-opening conversation th…
…
continue reading
1
Clinical Research Mergers, Secrets, and Shortcuts
27:03
27:03
Play later
Play later
Lists
Like
Liked
27:03
In this episode of Note to File, we dive into the recent merger between Circuit and Lightship, explore the behind-the-scenes challenges of clinical research site training, and discuss the ongoing consolidation in the clinical trial industry. Join us for candid insights, industry gossip, and a no-holds-barred conversation about the realities of clin…
…
continue reading
1
Wealth Management Invest: Rethinking Portfolio Diversification with Don Calcagni
35:11
35:11
Play later
Play later
Lists
Like
Liked
35:11
In this episode of the Wealth Management Invest Podcast, host David Bodamer sits down with Don Calcagni, the chief investment officer of Mercer Advisors, to explore how Mercer attempts to align investment decisions with financial goals. David and Don dive into defining clear investment objectives that align with clients’ financial aspirations, the …
…
continue reading
1
Mexico's Research Boom, Javara's Funding and Industry Gossip
25:03
25:03
Play later
Play later
Lists
Like
Liked
25:03
We discuss National Clinical Trials Day, Mexico's emerging clinical research landscape, and Javara's recent Series C funding. We dive into the challenges of oncology trials, explore the role of venture capital in healthcare, and share some industry gossip about Signant Health's recent job posting for a Director of Reputation and Crisis Communicatio…
…
continue reading
1
Wealth Management Invest: Demystifying Crypto for Financial Advisors with Kristen Mirabella
30:29
30:29
Play later
Play later
Lists
Like
Liked
30:29
In this episode of the Wealth Management Invest Podcast, host David Bodamer sits down with Kristen Mirabella, head of partnerships at Eaglebrook Advisors, to discuss the evolving role of cryptocurrency in wealth management. Eaglebrook is a digital asset platform that allows advisors to invest directly in crypto through separately managed accounts. …
…
continue reading
1
Digital Health, Clinical Trials, and Beyond with Matthew Holt - The Health Care Blog
54:11
54:11
Play later
Play later
Lists
Like
Liked
54:11
In this episode we sit down with healthcare veteran Matthew Holt, founder of The Health Care Blog and Health 2.0. Matthew shares his fascinating journey from Stanford grad student to healthcare technology commentator, offering candid insights into digital health, clinical trials, and the challenges of healthcare innovation. From discussing the pote…
…
continue reading
1
Clinical Research Confessions: PE, Trials, and Research Sins
30:21
30:21
Play later
Play later
Lists
Like
Liked
30:21
In this episode of Note to File, we dive deep into the world of clinical research, exploring the challenges of resident physician training, the impact of private equity on clinical trial management systems, and the often-unspoken ethical dilemmas in the field. Join us as we unpack difficult sponsor behaviors, share hilarious research confessions, a…
…
continue reading
1
Clinical Trials 2.0: AI, Predictions, and the Future of Research with Lokavant
48:59
48:59
Play later
Play later
Lists
Like
Liked
48:59
Special Pope election edition. In this episode, Rohit Nambisan from Lokavant and Jonathan Crowther from Pfizer discuss their innovative approach to clinical trial forecasting. They explore how advanced data analytics and AI can help predict and improve trial operational success, from site selection to protocol design. The conversation delves into r…
…
continue reading
1
CROs are Broken: Fixing Clinical Trials from the Inside Out with Meri Beckwith - Lindus Health
50:03
50:03
Play later
Play later
Lists
Like
Liked
50:03
In this episode, Meri Beckwith from Lindus Health discusses his journey from venture capital to clinical research, sharing insights on the inefficiencies of traditional CROs. He explains how Lindus is taking a different approach by aligning incentives, focusing on patient experience, and developing innovative trial models. The conversation explores…
…
continue reading
In this episode of Sticky Notes, Brad & Denali dive into the latest trends in clinical research, exploring how younger adults are getting medical advice from social media, the potential impact of pharmaceutical tariffs on R&D, and the evolving landscape of decentralized clinical trials. We discuss the challenges and opportunities of involving healt…
…
continue reading
We sit down with Bree Burks from Veeva to discuss the company's latest innovations in clinical research technology. We dive deep into Veeva's upcoming CTMS (Clinical Trial Management System), their strategy for connecting sponsors and sites, and the importance of creating more streamlined, user-friendly technology for clinical research sites. Bree …
…
continue reading
In this episode, Brad and Denali dive into recent industry developments, including Bay Pine's $1.5 billion acquisition of CenExel clinical research site network, the FDA's potential shift to AI-based animal testing alternatives, growing challenges with clinical trial recruitment and public trust, emerging pharmaceutical import tariffs, and the ongo…
…
continue reading
1
CAIS’s Brad Walker on Making Alternative Investments Accessible
28:38
28:38
Play later
Play later
Lists
Like
Liked
28:38
Join David Bodamer, Editorial Director at WealthManagement.com, and his guest, Brad Walker, Co-President at CAIS, as they delve into the transformative landscape of alternative investments. Discover why independent wealth managers and RIAs are increasingly incorporating alts into client portfolios and the innovative trends making this possible. Hig…
…
continue reading
In this episode Jim Kremidas, Executive Director of the Association of Multi-Site Research Corporations (AMRC), discusses the evolving landscape of clinical research sites. We explore how multi-site research corporations are working to improve operational efficiency, quality standards, and patient experiences in clinical trials. Kremidas shares ins…
…
continue reading
1
From The Archives: Jamie Massengill - SSM Health
1:02:43
1:02:43
Play later
Play later
Lists
Like
Liked
1:02:43
In this episode, we sit down with Jamie Massengill from SSM Health to unpack the complex world of clinical research in community healthcare. We dive deep into the challenges of launching successful research programs, exploring innovative partnership models, physician engagement strategies, and how community hospitals can transform clinical trials. …
…
continue reading
In this episode we talk with Chris Venezia, CEO of ProofPilot, about the often-overlooked operational challenges in clinical trials. Chris shares his unexpected journey into clinical research and reveals how ProofPilot is transforming the industry by simplifying communication, document sharing, and patient engagement. From addressing fundamental co…
…
continue reading
We talk to Science 37 CEO Tyler Van Horn and discuss the past, present and future of the company - everything you wanted to know about Science 37 but were afraid to ask.
…
continue reading
This episode is dedicated to feedback about the recent Save Our Sites (SOS) conference in Oklahoma City. The founders, Judy Galindo, Ashley Margot, Chris Sauber, Monica Cultiva and Dan Sfera join as we take live feedback from the livestream audience.
…
continue reading
A short recap of recent news, events, social media posts, gossip, announcements, and anything else in the clinical research space. In this episode Paul Ivsin joins to talk Science 37 v Science 38, PEs buyout of Walgreens and CRA/CRC relationships.
…
continue reading
1
Wealth Management Invest: Apollo’s Stephanie Drescher on Bringing Alts to the Wealth Channel
31:43
31:43
Play later
Play later
Lists
Like
Liked
31:43
Join David Bodamer as he sits down with Stephanie Drescher, Apollo’s chief client and product development officer, to unravel the potential of alternative investments for wealth advisors. David and Stephanie explore why Apollo is confident in hitting $150 billion in assets within the wealth channel and why traditional portfolios fall short without …
…
continue reading
Today we discuss vendor relationships , representation & its impact on business, diagnosis & after care - the main unmet need within pharma - and embroidery throwing.
…
continue reading
In this episode Dan Sfera joins us to cover the somewhat puzzling creation of the Association for Multisite Corporations (AMRC), a big time data breach from DM Clinical Research, and why everything in clinical research is an emergency.
…
continue reading
